WO2010089566A3 - Composition destinée au traitement de la peau - Google Patents

Composition destinée au traitement de la peau Download PDF

Info

Publication number
WO2010089566A3
WO2010089566A3 PCT/GB2010/000215 GB2010000215W WO2010089566A3 WO 2010089566 A3 WO2010089566 A3 WO 2010089566A3 GB 2010000215 W GB2010000215 W GB 2010000215W WO 2010089566 A3 WO2010089566 A3 WO 2010089566A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
skin
treatment
derived
stearidonic acid
Prior art date
Application number
PCT/GB2010/000215
Other languages
English (en)
Other versions
WO2010089566A4 (fr
WO2010089566A2 (fr
Inventor
Keith Coupland
Original Assignee
Seeds Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seeds Lp filed Critical Seeds Lp
Priority to CN2010800068593A priority Critical patent/CN102307624A/zh
Priority to US13/147,248 priority patent/US9403042B2/en
Priority to EP10703195A priority patent/EP2393557A2/fr
Publication of WO2010089566A2 publication Critical patent/WO2010089566A2/fr
Publication of WO2010089566A3 publication Critical patent/WO2010089566A3/fr
Publication of WO2010089566A4 publication Critical patent/WO2010089566A4/fr
Priority to US15/222,773 priority patent/US20170172964A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une composition comprenant un acide stéaridonique (ou un ester de celui-ci) dérivé par exemple de l'huile d'echium, et un lipide supplémentaire (dérivé par exemple de l'huile de calendula) qui améliore l'effet pro-collagène de l'acide stéaridonique. Ladite composition est utile dans la réduction des signes visibles du vieillissement de la peau d'un homme ou d'un animal ou dans une méthode de cicatrisation d'une blessure.
PCT/GB2010/000215 2009-02-06 2010-02-05 Composition destinée au traitement de la peau WO2010089566A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN2010800068593A CN102307624A (zh) 2009-02-06 2010-02-05 用于皮肤治疗的组合物
US13/147,248 US9403042B2 (en) 2009-02-06 2010-02-05 Composition for treatment of skin
EP10703195A EP2393557A2 (fr) 2009-02-06 2010-02-05 Composition destinée au traitement de la peau
US15/222,773 US20170172964A1 (en) 2009-02-06 2016-07-28 Composition for Treatment of Skin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0902040.5A GB0902040D0 (en) 2009-02-06 2009-02-06 Composition for treatment of skin
GB0902040.5 2009-02-06

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/147,248 A-371-Of-International US9403042B2 (en) 2009-02-06 2010-02-05 Composition for treatment of skin
US15/222,773 Continuation US20170172964A1 (en) 2009-02-06 2016-07-28 Composition for Treatment of Skin

Publications (3)

Publication Number Publication Date
WO2010089566A2 WO2010089566A2 (fr) 2010-08-12
WO2010089566A3 true WO2010089566A3 (fr) 2011-03-31
WO2010089566A4 WO2010089566A4 (fr) 2011-05-26

Family

ID=40469750

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2010/000215 WO2010089566A2 (fr) 2009-02-06 2010-02-05 Composition destinée au traitement de la peau

Country Status (5)

Country Link
US (2) US9403042B2 (fr)
EP (1) EP2393557A2 (fr)
CN (1) CN102307624A (fr)
GB (1) GB0902040D0 (fr)
WO (1) WO2010089566A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0814105D0 (en) 2008-08-01 2008-09-10 Springdale Sustainable Develop Composition for accelerated production of collagen
GB201010638D0 (en) 2010-06-24 2010-08-11 Seeds Lp Composition for treatment of skin
WO2013180490A1 (fr) * 2012-05-30 2013-12-05 한국생명공학연구원 Composition pharmaceutique pour la prévention et la réduction du vieillissement cutané, contenant un extrait d'aleurites fordii, sa fraction ou un composé diterpène isolé de ladite fraction en tant que principe actif
WO2016070194A1 (fr) * 2014-10-31 2016-05-06 Pomega, Inc. Compositions contenant de l'huile de pépins de grenade, de l'huile de fruits de rosa canina et de l'oléorésine ou de l'extrait d'inula viscosa
TWI615141B (zh) * 2016-06-23 2018-02-21 中國醫藥大學 α-桐油酸抗老化之用途
US10617613B2 (en) * 2018-04-30 2020-04-14 L'oreal Leave-on hair styling compositions and methods of use
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
JP7374986B2 (ja) 2018-07-27 2023-11-07 ジョンソン・アンド・ジョンソン・サージカル・ビジョン・インコーポレイテッド 眼を治療するための組成物及び方法
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340485B1 (en) * 1996-06-03 2002-01-22 Croda International Plc Compositions and uses thereof
EP0920300B1 (fr) * 1996-06-03 2003-04-09 CRODA INTERNATIONAL plc Compositions d'huile vegetale
WO2007004229A2 (fr) * 2005-07-06 2007-01-11 Rimonest Ltd. Methodes d'utilisation de fractions de grenades pour reparer la peau
US20070280898A1 (en) * 2006-06-06 2007-12-06 P & H Enterprises Of Marco Inc. Dermatological compositions
FR2902334A1 (fr) * 2006-06-16 2007-12-21 Nuxe Sa Lab Utilisation d'un extrait de souci dans une composition cosmetique.
WO2010013015A2 (fr) * 2008-08-01 2010-02-04 E.S.L.I. Limited Composition permettant une production accélérée de collagène

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9012651D0 (en) 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
JP2001253817A (ja) 2000-03-10 2001-09-18 Nagase & Co Ltd コラーゲン合成促進剤およびその製造方法ならびにコラーゲン合成促進剤を含有する皮膚外用剤。
WO2002024935A1 (fr) * 2000-09-20 2002-03-28 Basf Aktiengesellschaft Procede pour produire des glycerides a acides gras polyinsatures et conjugues a partir de leur alkylester
MXPA03010467A (es) 2001-05-14 2004-12-06 Martek Biosciences Boulder Corp Produccion y uso de una fraccion polar rica en lipidos que contienen acido estearidonico y acido gama-linolenico proviniente de semillas y microbios.
PL355298A1 (en) 2002-08-01 2004-02-09 DERMAPHYT Sp.z o.o. Dermatological preparation for curing skin defects
US20040161435A1 (en) 2003-02-14 2004-08-19 Gupta Shyam K. Skin Firming Anti-Aging Cosmetic Mask Compositions
FR2873295B1 (fr) * 2004-07-26 2006-12-01 Expanscience Sa Lab Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation
US20070150773A1 (en) 2005-12-19 2007-06-28 Nortel Networks Limited Extensions to SIP signaling to indicate SPAM
FR2903014B1 (fr) 2006-06-30 2008-09-26 Occitane L Composition cosmetique a base d'acide gras polyinsatures et ses utilisations
US20080213357A1 (en) 2007-02-12 2008-09-04 Andrew Bruce Hebard Plant Derived Lipid Useful for Nutraceutical and Cosemeceutical Applications

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340485B1 (en) * 1996-06-03 2002-01-22 Croda International Plc Compositions and uses thereof
EP0920300B1 (fr) * 1996-06-03 2003-04-09 CRODA INTERNATIONAL plc Compositions d'huile vegetale
WO2007004229A2 (fr) * 2005-07-06 2007-01-11 Rimonest Ltd. Methodes d'utilisation de fractions de grenades pour reparer la peau
US20070280898A1 (en) * 2006-06-06 2007-12-06 P & H Enterprises Of Marco Inc. Dermatological compositions
FR2902334A1 (fr) * 2006-06-16 2007-12-21 Nuxe Sa Lab Utilisation d'un extrait de souci dans une composition cosmetique.
WO2010013015A2 (fr) * 2008-08-01 2010-02-04 E.S.L.I. Limited Composition permettant une production accélérée de collagène

Also Published As

Publication number Publication date
GB0902040D0 (en) 2009-03-11
WO2010089566A4 (fr) 2011-05-26
US20170172964A1 (en) 2017-06-22
EP2393557A2 (fr) 2011-12-14
US20110293751A1 (en) 2011-12-01
WO2010089566A2 (fr) 2010-08-12
US9403042B2 (en) 2016-08-02
CN102307624A (zh) 2012-01-04

Similar Documents

Publication Publication Date Title
WO2010089566A3 (fr) Composition destinée au traitement de la peau
PH12018500843A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
UA108850C2 (uk) Екстракт цілісного насіння видів moringa та його застосування у косметичній та/або дерматологічній композиції
BR112012006692B8 (pt) composição farmacêutica compreendendo um derivado de hidróxi de atorvastatina e um óleo compreendendo etil eicosapentaenoato ou etil docosahexaenoato
EP2246042A3 (fr) Compositions et procédés pour traiter des signes de vieillissement de la peau
GB2459809A (en) Fatty acid formulations and methods of use thereof
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
EP2168570A3 (fr) Extraits d'isochrysis sp.
EP2318033B8 (fr) Compositions destinées au traitement de la douleur et/ou de l'inflammation
CO6571913A2 (es) Derivados de fumarato de ácido graso y sus usos
BRPI0511322A (pt) composições adequadas para o tratamento de sinais cutáneos provenientes do envelhecimento, tablete e formulação de tablete
WO2009101503A3 (fr) Utilisation de substances actives naturelles dans des compositions cosmétiques ou thérapeutiques
MX2011008448A (es) Uso de ester etilico del acido eisosapentaenoico para tratar hipertrigliceridemia.
EP2349348A4 (fr) Compositions et procédés de réduction des signes du vieillissement de la peau
WO2012163868A3 (fr) Composition comprenant un alcoxysilane, un ester gras et une silicone, et son utilisation en cosmétique
WO2010136900A3 (fr) Procédés d'utilisation de l'huile de krill à des fins de traitement des facteurs de risque associés aux affections métaboliques, cardiovasculaires et inflammatoires
EP2319488A3 (fr) Compositions comprenant un inhibiteur de NFkB et un promoteur de la tropoélastine
WO2008107092A3 (fr) Utilisation de dérivés d'acide 4-hydroxyphénoxy acétique
MX353580B (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.
WO2012075422A3 (fr) Compositions et méthodes pour traiter les symptômes associés à des plaques amyloïdes
WO2012088382A3 (fr) Alcool d'amyris et son ester pour le traitement de l'acné
WO2014030117A3 (fr) Utilisation cosmétique de l'huile essentielle de laserpitium siler l. contre les signes de vieillissement de la peau et comme antioxydant
BRPI0920020A2 (pt) relatório descritivo da patente de invenção: tratamentos de pele contendo derivados de idebenona substituida por ácido carboxílico e métodos de preparação.
EP2801356A3 (fr) DHA et EPA pour la réduction du stress oxydatif

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080006859.3

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10703195

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13147248

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 6512/DELNP/2011

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2010703195

Country of ref document: EP